Companies ›Basic Materials ›301683.SZ

301683.SZ — Shenzhen Stock Exchange Commodity Chemicals

Guangzhou Human New Material Science and Technology Co Ltd

¥129,75

Open in Charts → Attach watcher ⌖

— —

CNY

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

24,1 %

ROE

17,4 %

Net margin

21,0 %

Debt / equity

0,08

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

Guangzhou Human New Material Science and Technology Co Ltd is a chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Business. Guangzhou Human New Material Science and Technology Co Ltd (301683.SZ) is a Chinese company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in Guangzhou and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorBasic Materials

Business sectorChemicals

IndustryCommodity Chemicals

ActivityChemicals

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

17,4 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning 301683.

Sector rotation

Sector1D1Mvs mkt

Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to 301683.SZ. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Guangzhou Human New Material Science and Technology Co Ltd (301683.SZ) is a Chinese company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in Guangzhou and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorBasic Materials

Business sectorChemicals

IndustryCommodity Chemicals

ActivityChemicals

AI synthesis

GENERATED

Guangzhou Human New Material Science and Technology Co Ltd maintains a strong liquidity position, with a current ratio of 3.93, indicating the company can cover its short-term liabilities more than three times over. However, the company has a negative net cash position after subtracting total debt, which raises some liquidity concerns. The company's liquidity FPT (free cash flow to total liabilities) is not explicitly provided, but the operating cash flow of 185,119,200 CNY supports its ability to meet short-term obligations.

The company's profitability is robust, with a return on equity (ROE) of 17.41% and a return on assets (ROA) of 14%, both of which exceed the typical thresholds for the Commodity Chemicals industry. The net income of 206,786,400 CNY and operating income of 237,077,880 CNY further support the company's strong earnings performance.

The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic or regulatory risks, though the exact geographic breakdown is not available in the current dataset.

The company's growth trajectory is not explicitly outlined in the available data, but the operating cash flow and free cash flow figures suggest a stable and potentially growing business. The capital expenditure of -87,049,540 CNY indicates that the company is not currently investing heavily in new projects or infrastructure, which may suggest a conservative approach to growth.

The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The debt-to-equity ratio of 0.08 suggests a conservative capital structure with minimal leverage. However, the negative net cash position after subtracting total debt is a key flag that may require further monitoring.

There are no recent events or filings explicitly mentioned in the available data that would significantly impact the company's operations or financial position. The company's financials appear to be stable, with no immediate signs of distress or significant changes in its business model.

Key takeaways

Guangzhou Human New Material Science and Technology Co Ltd has a strong liquidity position with a current ratio of 3.93.
The company's profitability is robust, with a return on equity of 17.41% and a return on assets of 14%.
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.08.
The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
The company has a low dilution risk and a medium liquidity risk.
The company is not currently investing heavily in new projects, as indicated by its capital expenditure of -87,049,540 CNY.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

¥129,75

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

¥1.19B

Net cashⓘ

-¥89.7M

Current ratioⓘ

3.9

Debt / equityⓘ

0.1

ROAⓘ

14.0%

ROEⓘ

17.4%

Cash conversionⓘ

90.0%

CapEx / revenueⓘ

-8.8%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin24,1 %Best in class

Net Margin21,0 %Best in class

ROE17,4 %Best in class

Capex / Rev-8,8 %Below median

D/E0,08Above P75

Cash Conv0,90Below median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

Guangzhou Human New Material Science and Technology Co Ltd Market data — financials · 2026-05-26

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

301683.SZCanonical

Shenzhen Stock Exchange · CNY

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread